Jim Hollingshead
President and CEO, Insulet Corporation
Jim Hollingshead is a seasoned professional with over 15 years of experience in strategy consulting across the US and Europe. He holds a graduate degree in Political Science from the University of California, Berkeley, and an undergraduate degree in History and International Relations from Stanford University. Jim has held leadership roles at ResMed, a digital sleep therapy company, since 2010, progressing from Chief Strategy Officer to President of the Sleep Business and the newly formed Sleep and Respiratory Care Division, where he currently serves. Jim's expertise lies in accelerating company growth rates, diversifying business, and expanding market share. His expertise also extends to digital health and AI-ML in medical devices, having spearheaded cloud-based initiatives to connect devices and add value to therapy models. Jim has served on the Board of Directors at Insulet Corporation, a digital health and wearable disposable insulin pump manufacturer, and SleepScore Labs.